Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Vivasallergy-and-immunology

Paeds Vivas · allergy-and-immunology

Vaccination of immunocompromised children — branching viva

Branching viva on vaccinating the immunocompromised child: the threat gate that excludes a combined T-cell defect before any live vaccine, sorting each vaccine into live-attenuated versus inactivated, the corticosteroid threshold and its washout, timing after transplant and chemotherapy, household cocooning, and verifying serology after haematopoietic stem cell transplant.

branching clinical structured oral3 min readVerification in progress

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
On this page
Study tools

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
Primary care clinic: a four-month-old boy born overseas is due his routine immunisations. There is no newborn SCID screen on file; his maternal uncle died in infancy; he has persistent oral thrush and faltering growth. The examiner asks: what is your framework, what is the single most important safety decision today, which vaccines are at risk, how will you confirm or exclude the relevant defect, and what will you do about the inactivated vaccines and the household — then branches to a seven-year-old two years post-haematopoietic stem cell transplant, well and off immunosuppression, and asks you to justify rebuilding her entire schedule on evidence of reconstitution rather than her old record.

Opening framework

My framework has four questions, applied in order. First, what is the immune defect — could this be a combined T-cell defect, which is the one state that turns a safe live vaccine into fatal disease? Second, is the vaccine in question live-attenuated or inactivated, because that single sorting decides the safety question. Third, what is the timing relative to the immunosuppression — corticosteroid dose and duration, chemotherapy cycle, time since transplant. Fourth, how will I verify that the vaccine worked, because in this population a complete record does not equal immunity. [1]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References5ShowHide
  1. [1]Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis, 2014.PMID 24421306
  2. [2]National Center for Immunization and Respiratory Diseases. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, 2011.PMID 21293327
  3. [5]Gennery AR. Severe combined immunodeficiency: newborn screening and the BCG vaccination. Arch Dis Child, 2022.PMID 35973752
  4. [7]Bakare N, Menschik D, Tiernan R, et al. Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS). Vaccine, 2010.PMID 20674876
  5. [8]Hudspeth MP, et al. Post-hematopoietic stem cell transplant immunization practices in the Pediatric Blood and Marrow Transplant Consortium. Pediatr Blood Cancer, 2010.PMID 20135703
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousUrticaria and angioedema — branching vivaallergy-and-immunologyNextAnaemia: diagnostic approach — vivahaematology-oncology-and-transfusion